Introduction
Neoplasia is associated with a breakdown of the rules and regulations governing gene expression. The functional importance of transcriptional alterations in cancer is supported by the ability to classify accurately specific tumor subtypes based solely on global gene expression profiles (Golub et al., 1999; Perou et al., 1999; Alizadeh et al., 2000; Sorlie et al., 2001; Yeoh et al., 2002; Hedenfalk et al., 2003; Nutt et al., 2003) . Gene expression changes in cancer can result from mutation of transcription factors (Salomoni and Pandolfi, 2002; Scandura et al., 2002) or they can arise indirectly as a consequence of defects in multiple signal transduction pathways that lie upstream of transcriptional regulation (Sahai and Marshall, 2002; Downward, 2003) .
The discovery that human tumors harbor mutations in the cellular progenitors of retroviral oncogenes fueled two decades of intense research aimed at understanding the roles of proto-oncogenes and tumor suppressor genes in normal and abnormal cell growth. These studies revealed that, in many cases, oncogenes fulfill sequential functions in common signal transduction pathways, sometimes in direct association with each other. Thus, although the signal transduction pathways that go awry in tumorigenesis are dauntingly complex, they may ultimately converge on a limited subset of transcriptional regulatory mechanisms that dictate the transformed cell phenotype.
In addition to the numerous genetic abnormalities associated with cancer, it has become increasingly apparent that epigenetic changes mediated by DNA methylation and post-translational modifications of histones usurp the normal control of gene expression in tumor cells (Jones and Baylin, 2002) . To date, CpG methylation represents the most common epigenetic abnormality observed in tumors. CpG island hypermethylation and concomitant transcriptional silencing of tumor suppressor genes have been detected in various tumor types (Baylin and Herman, 2000) . Simultaneous with specific hypermethylation events, tumor cells often display global genomic hypomethylation of widespread repetitive sequences (Goelz et al., 1985; Feinberg et al., 1988) . These changes can also contribute to tumorigenesis, possibly by promoting chromosomal instability Gaudet et al., 2003) . Therefore, defects in systems that maintain the 'epigenome' may accelerate tumorigenesis by inducing changes in chromatin structure or chromosomal integrity, thus impacting the expression of numerous genes. A more comprehensive understanding of these epigenetic abnormalities and their functional contributions to tumorigenesis depends in part on the identification of genes that are epigenetically deregulated within experimentally amenable systems.
The expression of the viral fos oncogene or inappropriately sustained expression of c-fos results in cellular transformation in vitro and tumorigenesis in vivo (Miao and Curran, 1994; Bakin and Curran, 1999) . Previously, we identified DNA (cytosine-5) methyltransferase-1 (Dnmt1) as a gene involved in the mechanism of cellular transformation by the c-fos oncogene (Bakin and Curran, 1999) . Furthermore, increased expression of DNMT1 has been detected in human tumor cells (Kautiainen and Jones, 1986; el-Deiry et al., 1991; Issa et al., 1993) . Increased expression and activity of Dnmt1 is necessary for full morphological transformation by Fos, and ectopic expression of the oocyte-specific isoform of Dnmt1 is sufficient to induce cellular transformation . Inhibition of CpG methylation and histone deactylation by 5-aza-2 0 -deoxycytosine (5-aza-dC) and trichostatin A (TSA) leads to a morphological reversion of Fos-transformed cells to a nontransformed phenotype (Bakin and Curran, 1999) . Together, these findings suggest that cell transformation by Fos may recapitulate aspects of the breakdown of epigenetic control associated with cancer.
Dnmt1 has also been implicated in the transforming mechanism of constitutively active Ras (MacLeod et al., 1995) . The ras oncogene encodes a monomeric GTPbinding protein that couples signaling events at the cell surface to the activation of downstream signaling pathways important in normal growth regulation (Downward, 2003) . These signaling events include pathways that activate Fos as well as Fos-independent pathways (Stacey et al., 1987) . Subtractive cDNA-based approaches have been performed to identify gene expression profiles in cells transformed by RAS (Zuber et al., 2000) or by v-fos (Johnston et al., 2000) . Furthermore, the latter study demonstrated that largescale gene expression analysis can be employed to identify transcriptionally repressed genes that are functionally involved in the suppression of the cell transformation phenotype. In this study, we have utilized a microarray-based approach to identify gene expression changes common among cells transformed by ectopic expression of c-fos, v-fos, ras or Dnmt1. We show that although each cellular transformation system features both increased and decreased expression of large numbers of genes, the intersect of the data sets includes an over-representation of repressed genes, further emphasizing the role of transcription repression in oncogenesis. Treatment of transformed cells with inhibitors of DNA methylation and/or histone deacetylation identified four potential tumor suppressor genes (bone morphogenetic protein 4 (BMP4), N-cadherin, src-suppressed C kinase substrate (Ssecks) and lost on transformation-1 (Lot1)) that are transcriptionally repressed via epigenetic mechanisms during cellular transformation. We found that promoter region hypermethylation is associated with the repression of each of these genes. However, the association between DNA hypermethylation and repression of transcription appears to depend on whether the genes are conditionally downregulated or irreversibly silenced during conditional v-fos cellular transformation. These findings suggest that distinct routes of oncogenic transformation may involve common mechanisms of transcription repression. Furthermore, the results identify a group of transformation-relevant genes that may represent endogenous targets suitable for further studies aimed at understanding the temporal mechanisms of epigenetic gene repression in cancer.
Results
To identify genes differentially expressed during oncogenic cellular transformation, we compared gene expression profiles of fibroblasts transformed by c-fos (CMVc-fos), v-fos (FBJ/R), Dnmt1o (CMVdnmt1) or constitutively active ras (rasV12) to the parental 208F rat fibroblast cell line (Figure 1a-e) . As expected, ectopic expression of fos results in differential expression of a large number of genes (Figure 1f ). Although sustained expression of c-fos is sufficient to induce cellular transformation in vitro and tumorigenesis in vivo, v-fos is a more potent oncogene. This difference is reflected by the increased number of upregulated genes in cells transformed by v-fos relative to c-fos, suggesting that the increased oncogenic potential of v-fos is a consequence Black bars represent the number of genes scored as increased by at least a factor of 2 (signal : log ratio X1). Gray bars represent the number of genes scored as decreased by at least a factor of 2 (signal : log ratio p1). Cell lines and combinations of cell lines are indicated above the graph. The data include the total number of probe sets (less probe sets representing ESTs) scored as differentially expressed rather than the number of independent differentially expressed genes. However, within this data set, there are no biases toward replicated addresses scored as either up-or downregulated. The percentage of present calls determined in comparisons of each cell line to 208F cells is indicated below the graph Interpretation of gene expression data derived from cell lines is complicated by potential differences due to clonal variation and gene expression changes that occur downstream of the oncogenic process. Therefore, analyses of cellular model systems that allow reversible control of oncogene expression and cellular transformation provide an effective compliment for the identification of gene expression changes relevant to oncogenesis (Miao and Curran, 1994; Bakin and Curran, 1999) . Therefore, we produced a 208F-derived cell line that allows reversible morphological transformation dependent on controlled expression of v-fos (LacIv-fos). The LacIv-fos system is based on the previously reported Lac-activator strategy (Labow et al., 1990) . The presence of IPTG in the culture media prevents the expression of v-fos, and LacIv-fos cells remain in a nontransformed morphological state. Upon removal of IPTG, v-fos expression is induced by the Lac-activator fusion protein, and morphological transformation occurs within 72 h. Readdition of IPTG again prevents the expression of v-fos, and the cells revert to the initial morphology within 72 h (Figures 2a-g and 3b) .
We extended our microarray studies to include an analysis of gene expression throughout a 6-day LacIvfos transformation/reversion time course. RNA samples harvested at an initial time point in the presence of IPTG (t ¼ 0), at 24, 48 and 72 h after removal of IPTG (transforming), and at 24, 48 and 72 h after readdition of IPTG (reverting) were subjected to microarray analysis to provide relative measurements of gene expression. Surprisingly, the Affymetrix U34A rat GeneChip includes a probe set representing the FBR proviral genome (X03347cds_at). Comparisons of signal values obtained at this probe set compared to probe sets representing c-fos indicate that X03347cds_at is specific for v-fos transcripts and does not crosshybridize with cfos transcripts. Although it is not apparent why the rat genome microarray includes a probe set for a mouse osteosarcoma retroviral oncogene, its inclusion provides a convenient internal control for our studies (Figure 2g ). Conditional v-fos expression was independently confirmed by Northern analysis (Figure 3b ). For the studies presented here, we restricted our analyses to the cohort of genes commonly repressed in the stably transformed cell lines. A comprehensive analysis of gene expression patterns throughout v-fos transformation and reversion will be published elsewhere, and access to the complete time-course data set will be made available at that time.
Similar to cellular transformation by c-fos (Bakin and Curran, 1999) , conditional transformation by v-fos is directly correlated with increased expression and activity of Dnmt1 (Figure 2h and data not shown). The induction of Dnmt1 expression during LacIv-fos transformation is not an artifact due to media change. Serum-induced effects on gene expression would be similar following both removal and readdition of IPTG rather than specifically associated with v-fos expression. We compared data sets derived from the intersect of CMVc-fos, FBJ/R, rasV12 and CMVdnmt1 cells to the LacIv-fos time-course data to identify genes differentially expressed in all model systems. Among the 51 genes repressed in all four stably transformed lines, 21 genes (41%) were conditionally repressed in the LacIvfos transformation/reversion time course (Table 1) . Expression of these genes decrease during morphological transformation and return to pretreatment levels during reversion (Figure 3 ). An additional 18 genes (35%) were repressed throughout the time course (Table 1) . It is important to note that stable repression or silencing of genes throughout LacIv-fos transformation and reversion does not exclude a functional role in the processes of cellular transformation. During the establishment of the LacIv-fos cell line, clones were necessarily isolated based on morphological transformation and reversion in the absence and presence of IPTG, respectively. These gene repression events could contribute to initial phases of cellular transformation that are independent of cell morphology. Since each of these genes is expressed in the parental 208F cell line, we infer that this group represents genes that are repressed during the initial stages of transformation and remain repressed following morphological reversion. One gene within this group, SM22, displayed a minor and transient induction of expression 24 h following removal of IPTG, which was not detected by microarray analysis (Figure 3b ). This demonstrates that although each gene in this group is repressed throughout the transformation/reversion time course relative to nontransformed cells, this repression is not completely stable in every case. Expression of the remaining 12 genes (24%) did not change in a consistent pattern during v-fos transformation and reversion (Table 1 ). The differential expression of these genes in the stably transformed cells may be due to expression changes that occur well downstream of the initial transformation process. We confirmed the predicted expression patterns of 10 genes by Northern analysis or reverse transcription-PCR (RT-PCR) (examples shown in Figures 3b and 4a) . We discovered only one incorrectly identified gene in the microarray data set. Although insulin-like growth factor 2 (Igf2) was scored as downregulated in all four stably transformed cell lines, we could not detect the expression of Igf2 in the parental 208F cell line by RT-PCR.
To address the contribution of aberrant DNA methylation to these gene expression changes, we analysed the expression of repressed genes following 
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Cytosolic 3 (Jones, 1985; Christman, 2002) . Furthermore TSA, an inhibitor of histone deacetylases, acts synergistically with 5-azadC to further increase the expression of DNA methylation-dependently repressed genes (Cameron et al., 1999; Suzuki et al., 2002) . Genes that were stably repressed throughout conditional v-fos transformation and reversion (Table 1) were analysed by RT-PCR (Figure 4a ). Treatment with 5-aza-dC, TSA or both reactivated the expression of two silenced genes (BMP4 and Ncadherin) in CMVdnmt1 cells (Figure 4a ). These results suggest that repression may have been mediated by promoter hypermethylation. Furthermore, their induced expression confirms that the identification of the cohort of irreversibly repressed genes is not exclusively the result of karyotypic abnormalities, resulting in permanent gene disruptions. It is important to note that the drug concentrations used in these studies were chosen to ensure minimal toxicities for each cell line (see Materials and methods). To avoid transcription changes associated with cell death rather than drug-induced transcriptional reactivation, we used the highest drug concentrations that induced morphological reversion with no significant effect on cell viability. The different drug concentrations used to treat the stably transformed cell lines are likely to be responsible for the differential sensitivities of BMP4 and N-cadherin to drug-induced reactivation in FBJ/R and rasV12 cells relative to CMVdnmt1 cells because treatment with more toxic doses of 5-aza-dC and TSA results in induced expression of BMP4 and N-cadherin in all three cell lines (data not shown). Other genes, such as distaless 3, showed no detectable expression even in the presence of both drugs. Finally, expression of a few genes such as adrenomedulin and Ssecks was detected by RT-PCR even in mock-treated transformed cells, suggesting that these genes are repressed in transformed cells, but not silenced.
Several genes are conditionally downregulated specifically during transient LacIv-fos transformation ( Figure 3 ). We were unable to assay the responsiveness of these genes to 5-aza-dC and TSA by RT-PCR because their expression tended to be repressed, but not completely silenced in transformed cells. Therefore, we produced low-density cDNA nylon filter arrays including 20 genes, spotted in duplicate, plus internal normalization controls (see Materials and methods). Duplicate filters were hybridized to radiolabeled complex cDNA probes produced from mock-treated 208F, FBJ/R, rasV12 or CMVdnmt1 cells, or the same cells treated with 5-aza-dC plus TSA. The normalized ratios of hybridization intensities for drug-treated vs mocktreated cells were calculated. Two genes were scored as upregulated following drug treatment in transformed cells relative to 208F cells, Ssecks (ortholog of human Gravin) and Lot1 (ortholog of human LOT1 and mouse Zac1). Northern analyses confirmed these results (Figure 4b ). Both Ssecks and Lot1 were highly expressed in 208F cells, and expression was barely detectable or silenced in FBJ/R, rasV12 and CMVdnmt1 cells. Expression of these two genes, but not other genes represented on the filter array, was induced in rasV12 and CMVdnmt1 cells following the drug treatment. However, drug treatment did not significantly induce expression of Ssecks or Lot1 in FBJ/R cells.
These findings suggest that BMP4, N-cadherin, Ssecks and Lot1 may be repressed by an epigenetic mechanism shared by distinct oncogenic pathways. Interestingly, the known functions of each of these genes imply that loss of expression could contribute to tumorigenesis. Analyses of the available sequence data for these genes predict that each includes a CpG island extending into the 5 0 transcribed region (EMBOSS CpGPLOT). To further investigate the mechanisms of repression of these genes, we analysed the CpG methylation status of their 5 0 regulatory regions. These studies are somewhat hampered by the limited availability of rat genomic DNA sequence 5 0 to the coding regions of the four genes. Therefore, we used a previously reported technique based on DNA affinity chromatography (Cross et al., 1994) to measure changes in CpG methylation densities within the 5 0 regulatory regions of the candidate genes. This approach takes advantage of the methyl-CpG-binding characteristics of the methyl-CpG-binding domain (MBD) of MeCP2, a DNA methylation-dependent transcription corepressor (Lewis et al., 1992; Jones et al., 1998; Nan et al., 1998) . The MBD binds DNA containing a single symmetrically methylated CpG dinucleotide in vitro, and its DNAbinding affinity is directly proportional to methyl-CpG density (Lewis et al., 1992; Cross et al., 1994) . To evaluate the methyl-CpG-binding characteristics of the MBD column, plasmid DNAs that have been differentially methylated in vitro with bacterial methylases were passed over the column and eluted with a linear salt gradient. The plasmid DNAs elute in three distinct peaks dependent on CpG methylation density ( Figure  5a and b) .
To analyse CpG methylation densities of endogenous loci, we digested genomic DNA from 208F, FBJ/R, rasV12 and CMVdnmt1 cells with MseI. This enzyme cuts at TTAA sequences that occur frequently outside, but rarely within, CpG islands. Digested genomic DNAs were passed over the MBD affinity column and eluted in a linear salt gradient. The presence of specific CpG island fragments was assayed by PCR. Primers were designed to amplify a region within the genomic MseI fragment that included the CpG island. As controls, two endogenous CpG islands with known methylation status were analysed. The b-actin gene includes a large hypomethylated CpG island containing over 100 CpG dinucleotides. The rat testes-specific histone 2B gene (TH2B) includes a relatively small CpG island that is (Choi and Chae, 1991) . While the hypomethylated b-actin CpG islands generally eluted at less than 600 mM NaCl, the hypermethylated TH2B CpG islands eluted at NaCl concentrations greater than 600 mM (Figure 5c-e) . A summary of the FPLC fractionation analyses of the CpG islands associated with the 5-aza-dC/TSA-responsive genes is shown in Figure 5f . The percentage of the CpG island fragments from the silenced BMP4 and N-cadherin genes that eluted in the heavily methylated fractions was dramatically increased in rasV12, FBJ/R and CMVdnmt1 cells relative to 208F cells, indicating that transcription repression of these genes was associated with promoter hypermethylation in all three transformed lines. Ssecks and Lot1 demonstrated a significant level of CpG methylation even in nontransformed 208F cells. For Lot1, this is expected since it is an imprinted gene that is methylated on the maternally inherited allele (Piras et al., 2000) . However, genomic imprinting of the rat Ssecks gene has not been reported previously. The percentages of Ssecks and Lot1 CpG island fragments eluted in the heavily methylated fractions were increased in rasV12 and CMVdnmt1 cells, but not in FBJ/R cells. These results are in agreement with the 5-aza-dC/TSA induction data presented in Figure 4b . While drug treatment resulted in dramatic upregulation of Ssecks and Lot1 expression in rasV12 and CMVdnmt1 cells, expression of these genes remains repressed in FBJ/R cells. Therefore, although BMP4 and N-cadherin are silenced in association with promoter hypermethylation in all three transformed cell lines, repression of Ssecks and Lot1 in FBJ/R cells occurs independent of increased CpG methylation. These results suggest that either different oncogenic pathways maintain gene repression of com- 
Discussion
Numerous molecular pathways contribute to oncogenic transformation and tumorigenesis. In this study, we have taken a large-scale gene expression analysis approach to identify transcriptional changes common among cells transformed by distinct but related oncogenes. Although efforts to identify genes important in oncogenic transformation often focus on transcriptionally upregulated genes, our results implicate a common cohort of transcriptionally repressed genes in cellular transformation. This group includes several genes with demonstrated or implied roles in transformation and tumorigenesis. Although our analyses included cells morphologically transformed by ectopic expression of Dnmt1, the cohort of repressed genes includes epigenetically regulated targets as well as genes repressed apparently independent of DNA methylation. Therefore, transcriptional repressive mechanisms including, but not limited to changes associated with aberrant DNA methylation, may be shared among distinct oncogenic pathways, resulting in the repression of groups of genes involved in the suppression of the transformation phenotype.
Recent discoveries have elaborated the Byzantine complexity of the mechanisms, whereby reprogramming of chromatin packaging affects gene expression. These pathways are modulated by interdependent epigenetic hallmarks including cytosine methylation, histone lysine methylation, histone lysine acetylation and other specific modifications. Among the common cohort of repressed genes, we identified four genes that can be transcriptionally reactivated by the inhibition of DNA methylation and histone deacetylation (BMP4, N-cadherin, Ssecks and Lot1). During conditional v-fos transformation, the expression patterns of these genes fit into three distinct categories. Two are stably silenced throughout the transformation and reversion time course (BMP4 and N-cadherin). Ssecks is continually repressed during v-fos transformation and reversion; however, its expression is not completely silenced. Finally, expression of Lot1 is conditionally repressed specifically during v-fos morphological transformation. Both stably silenced genes (BMP4 and N-cadherin) demonstrated increased CpG methylation within the promoter region in all three cellular transformation lines analysed (FBJ/R, rasV12 and CMVdnmt1). Genes that were repressed, but not continually silenced during conditional v-fos transformation (Ssecks and Lot1), were found to exhibit increased CpG methyaltion within the promoter region in rasV12 and CMVdnmt1 cells, but not in FBJR cells. Therefore, transcriptional downregulation of common target genes may be initiated by common mechanisms independent of DNA methylation, yet progression of the repressed state to a stably silenced state is associated with DNA hypermethylation. This process appears to depend both on the identity of the repressed gene and on the specific oncogenic cellular environment. For example, BMP4 and N-cadherin proceed to a hypermethylated silenced state in cells transformed by v-Fos, Ras or Dnmt1. However, in v-Fos-transformed cells, repression of Ssecks and Lot1 expression was incomplete and it was independent of DNA methylation status. Future studies aimed at determining the precise combinations of DNA and histone modifications at these loci in v-Fostransformed cells relative to rasV12 and CMVdnmt1 cells may provide insights into the stepwise mechanisms leading to DNA methylation-dependent gene silencing during oncogenic transformation.
Interestingly, each of the four epigenetically repressed genes encode proteins with potential or demonstrated roles in transformation and tumorigenesis, suggesting either an inherent predisposition of these loci to epigenetic deregulation or a strong selective pressure for silencing even within an ex vivo environment. To our knowledge, inactivation of CDH2 (the human orthologe of rat N-cadherin) has not been previously correlated with cellular transformation or tumorigenesis. However, both genetic and epigenetic events resulting in the loss of CDH1 (E-cadherin) function are associated with various tumor types (Graff et al., 1995; Yoshiura et al., 1995; Tamura et al., 2000) , and disruption of cadherin-catenin complexes occurs in various carcinomas and is correlated with tumor dedifferentiation, metastasis, infiltration and poor prognosis (Hajra and Fearon, 2002) . As members of the TGF-b superfamily of secreted signaling molecules, BMPs regulate numerous cellular processes central to tumorigenesis including differentiation, proliferation, apoptosis, adhesion and migration (Dale and Jones, 1999) , and in vitro evidence supports a role for BMPs in the negative regulation of neoplastic growth (Kleeff et al., 1999; Raida et al., 1999) . Furthermore, predicted loss-of-function mutations in bone morphogenetic protein receptor 1A, a serine/threonine kinasetype receptor that mediates BMP-induced intracellular signaling (Kretzschmar et al., 1997; Henningfeld et al., 2000) , are associated with juvenile polyposis, an autosomal dominant gastrointestinal hamartomatous polyposis syndrome linked to increased risk for developing colorectal cancers (Howe et al., 2001) . Interestingly, TGF-b3 expression is also repressed in cells transformed by Fos, Ras or Dnmt1, and this repression is unresponsive to 5-aza-dC and TSA treatment. BMP and TGF-b proteins function through converging signaling pathways involving the SMAD transcription factor family (Heldin et al., 1997) . Therefore, our results raise the possibility that common oncogenic pathways may involve a combination of epigenetic and nonepigenetic transcription repression events that cooperate to disrupt distinct steps within interconnected signaling networks critical for tumor suppression.
SSeCKS (the rat ortholog of human Gravin/ AKAP12) functions in both the organization of the actin-based cytoskeleton (Lin et al., 1996) and in mitogenic control by the regulation of expression and localization of cyclin D1 (Lin et al., 2000) . Repression of Ssecks expression has been implicated in the transformation mechanisms of v-src (Lin et al., 1995; Lin and Gelman, 1997) and v-Jun (Cohen et al., 2001) , and its expression is reduced in human breast epithelial cells (Zhang et al., 1995) and rat prostate cancer cell lines (Xia et al., 2001) . These findings support the classification of Ssecks as a tumor suppressor gene. However, an epigenetic mechanism for repression of Ssecks has not been reported previously. Lot1 (orthologous to human LOT1 and mouse ZAC1) is a zinc-finger nuclear transcription factor originally identified as a repressed gene in malignant rat ovarian surface epithelial cells (Abdollahi et al., 1997; Huang and Stallcup, 2000) . Functional studies indicate that LOT1 functions in growth suppression through signaling pathways involving induction of both apoptosis and cell cycle arrest (Spengler et al., 1997; Varrault et al., 1998; Abdollahi et al., 1999; Bilanges et al., 2001) . Hypermethylation of the promoter region CpG island of the paternal allele has been suggested to contribute to transcriptional silencing of LOT1 in breast and ovarian cancers Abdollahi et al., 2003) .
The process of cellular transformation requires cooperative contributions of defects in various complex cellular pathways. These defects can be driven by either increased or decreased expression of genes that function within those pathways. Determination of the functional contributions of differentially expressed candidate genes to transformation is often experimentally difficult because recapitulation of individual gene expression changes in nontransformed cells do not reflect their cooperative effects within the context of the transformed cell. However, identification of groups of differentially expressed genes that potentially act in concert across distinct modes of cellular transformation may narrow the focus to cooperative mechanisms that go awry in tumorigenesis. Our results emphasize the importance of transcriptional repression in oncogenic transformation, and they identify a cohort of transcriptionally repressed genes common among distinct cellular transformation systems. Recent advances in RNA interference technologies (McManus and Sharp, 2002; Shi, 2003) may permit experimental manipulation of cohorts of these gene repression events to test their cooperative functional contribution to transformation. Furthermore, we have identified a subset of genes subject to transcriptional repression by an epigenetic mechanism. Since epigenetic modifications do not involve mutations in DNA sequence, their potential reversibility implies that genes repressed by these mechanisms in tumors are attractive therapeutic targets (Cheng et al., 2003; Li et al., 2003) . Investigations of the effects of such strategies on epigenetically repressed loci in transformed cells will aid in the evaluation of the benefits of therapeutic disruption of epigenetic repressive mechanisms relative to the potential risks of promoting chromosomal instability Gaudet et al., 2003) .
In terms of the role of Dnmt1 in cellular transformation by Fos and ras, our results support the hypothesis that CpG island hypermethylation is a downstream event that locks in a transcriptionally silenced state of specific downregulated genes. However, these findings do not exclude an active involvement of Dnmt1 in the initiation of repression of specific genes. For example, Dnmt1 interacts directly with transcriptional repression components, including histone deacetylases and other corepressors, potentially recruiting them to specific target genes (Fuks et al., 2000; Robertson et al., 2000; Rountree et al., 2000; Di Croce et al., 2002; Kimura and Shiota, 2003) . The identification of potential tumor suppressor genes that are commonly epigenetically repressed in experimentally amenable model systems of cellular transformation may permit delineation of the temporal molecular mechanisms that promote these transcriptional repressive events, the impacts of these transcription regulatory defects on normal cell physiology, and routes to circumvent these repressive mechanisms in tumors.
Materials and methods

Production of the LacIv-fos conditional transformation line
Construction of pLAP348 and pL1-3CAT has been described previously (Labow et al., 1990) . To create a plasmid for conditional expression of v-fos, a 160 bp fragment from pL1-3CAT, including the enhancerless SV40 early promoter, was inserted into the BamHI and PstI sites of pBluescript II KS þ to create pLSVPII. A 200 bp fragment including the SV40 polyadenylation signal was amplified by PCR using pREP4 (Invitrogen) as template and primers that included an upstream XbaI site and downstream SacII site, and this fragment was ligated into XbaI/SacII-digested pLSVPII. Three 23 bp fragments including the Lac operator sequence were produced by annealing synthetic oligonucleotides and sequentially ligated into pLSVPII between the KpnI and PstI sites to create pLacO3pA. A 1.8 Kb fragment including the entire FBJ/R coding region was excised from pFBJ/RNeo (Miller et al., 1985) with AatII and HindIII, blunt-ended with mung bean nuclease (New England Biolabs) and ligated to SpeI-digested, blunt-ended pLacO4pA to create pLacO4FBJ/R. The engineered FBJ/R oncogene consists of the 5 0 -end of FBJ fused to the downstream region of FBR. This fusion lacks the gag region of FBR and encodes a v-Fos protein with high transforming activity (Miller et al., 1985) .
The 208F rat fibroblasts were transfected with 0.5 mg pLacO3FBJ/R, 4 mg pLAP348 and 0.5 mg pSVNeo using Fugene 6 transfection reagent (Roche). After 48 h, cells were split 1 : 10 by trypsinization and seeded in DMEM media containing 10% fetal calf serum (FCS), 0.4 mg/ml G418 (Gibco), X-glutamine and penicillin/streptomycin. After several days in culture, morphologically transformed, G418-resistant foci were picked using a sterile pipette and subcloned into 12-well tissue culture plates. Cells were expanded in the presence of 5 mM IPTG, then tested for the ability to morphologically transform following removal of IPTG and revert following readdition of 5 mM IPTG. One suitable subclone (3F263) was expanded in 5 mM IPTG and frozen in DMEM containing 20% FCS and 10% DMSO (LacIv-fos).
Microarray gene expression analyses
All cells were maintained in DMEM supplemented with 10% FCS, L-glutamine and penicillin/streptomycin at 371C and 5% CO 2 . Total RNA was extracted from subconfluent cultures of 208F, FBJ/R, CMVc-fos, rasV12 and CMVdnmt1 cells with Tripure reagent using the manufacturer's protocol (Roche). The establishment of the stably transformed cell lines was described previously (Bakin and Curran, 1999) . For the v-Fos transformation and reversion time-course experiment, total RNA was extracted from LacIv-fos cells cultured in the presence of 5 mM IPTG (t ¼ 0), following removal of IPTG for 24, 48 and 72 h (transforming), and following readdition of 5 mM IPTG for 24, 48 and 72 h (reverting). Integrity of all RNA samples was verified using an Agilent 2100 Bioanalyzer. RNA samples were processed for hybridization without amplification and hybridized to Affymetrix Rat Genome U34A GeneChips that include probe sets representing approximately 7000 annotated genes and 1000 EST clones (http://www.affymetrix.com/products/arrays/specific/ rgu34.affx). Labeling and hybridization were preformed as described (http://www.narf.vcu.edu/Affymetrix%20protocol. doc). GeneChips were scanned using a laser confocal scanner (Agilent Technologies), and images were analysed using Affymetrix Microarray Suite v.5.0. Data sets were standardized by global scaling of the average fluorescent intensities of all probe sets to a constant target value of 500 for all arrays. Quality control parameters for each hybridization were within MIAME compliant specifications (Brazma et al., 2001) http:// www.mged.org/Workgroups/MIAME/miame.html). For the identification of gene expression changes in CMVc-fos, FBJ/ R, rasV12 and CMVdnmt1 cells, genes scored as differentially expressed met the following criteria in all four comparisons to 208F cells: change call of I (increased) or D (decreased), signal log ratio X1 (increased) or pÀ1 (decreased) and change P-value o0.001566 (increased) or 40.998696 (decreased). Probe sets representing ESTs are not included in the data presented. However, complete data sets including ESTs are available (http://hc-apps3.web.stjude.org:8889/data/ordwayetal). For visualization of specific gene expression profiles during the LacIv-fos conditional transformation and reversion time-course, signal values obtained for each LacIv-fos time point were plotted using Microsoft Excel. To standardize expression values for genes scored as absent, signal values corresponding to 'A' detection calls were converted to 1.
Northern and RT-PCR analyses
Northern analyses were performed by standard protocols. Probes were generated by RT-PCR using 208F total RNA as template for first-strand cDNA synthesis (SuperScript II system, Invitrogen), followed by PCR amplification (Qiagen) using gene-specific primer sets. All primers used in this study were designed by Vector NTI software (InforMax, Inc.). For RT-PCR analyses, 1 mg total RNA extracted from drug-or mock-treated cells was used as template for first-strand cDNA synthesis, followed by PCR amplification using gene-specific primer sets. All primer sequences and detailed PCR protocols are available upon request. RT-PCR products were electrophoresed in 2% agarose/TAE gels and visualized by staining with GelStar (BioWhittaker Molecular Applications, Rockland, ME, USA).
5-aza-dC and TSA treatments
Cells were maintained in culture as described above. Cell linespecific drug toxicities were determined empirically by culturing each line for 3 days in the presence of a range of 5-aza-dC, TSA or 5-aza-dC plus TSA concentrations. The highest concentrations that induced a change in cellular morphology but minimal cell death were chosen for further studies. Cells treated with 5-aza-dC or TSA alone were cultured in the presence of drug for 72 h prior to total RNA extraction as described above. 5-aza-dC concentrations were 500 nM (208F, FBJ/R, rasV12 and CMVdnmt1). TSA concentrations were 300 nM (208F and rasV12) or 100 nM (FBJ/R and CMVdnmt1). Cells treated with both 5-aza-dC and TSA were cultured in the presence of 5-aza-dC for 48 h. TSA was added, and cells were cultured for an additional 24 h prior to total RNA extraction as described above (Cameron et al., 1999) . Drug concentrations were 500 nM 5-aza-dC (208F, CMVc-fos, FBJ/R, rasV12 and CMVdnmt1) plus 300 nM TSA (208F), 100 nM TSA (FBJ/R and CMVdnmt1) or 50 nM TSA (rasV12). RT-PCR analyses were performed as described above.
Production and screening of nylon filter arrays
Probes were produced by RT-PCR as described above. RT-PCR (100 ng) products were suspended in 0.4 N NaOH and spotted onto Hybond-N þ filters (Amersham) using a HybriDot vacuum manifold (Life Technologies). Rat genes represented on filters include b-actin, PXEL, Bus19, NGFIA, CIRL-2, osteoadherin, collagen a 1 type V, serine protease, GST Y-b, IP3 receptor, kidney Zn-peptidase aminopeptidase N, rOAT, glutamate transporter, lysosomal acid lipase, TGF-b3, smLIM, KZF-1, Lot1, Krox24, Ssecks, GAX, protein tyrosine phosphatase-like protein and 53 kDa induced by growth factors and oncogenes (see Table 1 for accession numbers). 32 P-dCTP-labeled complex probes were produced from total RNA samples from mock-treated and 5-aza-dC plus TSAtreated 208F, FBJ/R, CMVdnmt1 and rasV12 cells. Total RNA (10 mg) was used as template for first-strand cDNA synthesis using oligo-dT primer and Superscript II reverse transcriptase (Invitrogen). Duplicate filters were probed with 2.7 Â 10 7 c.p.m. probe under standard Southern blot conditions. Washed filters were phosphorimaged and signal intensities were determined by ImageQuant. Hybridization intensities were normalized to the averaged hybridization intensity of eight b-actin control spots on the same filter. For each gene, the ratio of the drug-treated intensity to the mocktreated intensity was calculated for each cell line.
DNA affinity chromatography-based analysis of CpG methyaltion density
The MBD of rat MeCP2 was expressed as a 6-histidine-tagged fusion protein, purified and used to produce a DNA affinity chromatography column as described (John and Cross, 1998) . To test the DNA-binding properties of the column, plasmid DNA was linearized and treated with no methylase, HhaI and HpaII methylase (24 methylated CpGs) or SssI methylase (138 methylated CpGs). Plasmids were mixed, passed over the column and eluted in a linear NaCl gradient from 0.1 to 1.0 M NaCl. Methylation status of DNA in each peak was analysed by digestion with methylation-sensitive restriction enzymes as indicated in Figure 5 .
Genomic DNA (100 mg) from 208F, FBJ/R, rasV12 or CMVdnmt1 cells was digested with MseI, purified by phenol : chloroform extraction and resuspended in 1 ml HMBD buffer (20 mM HEPES (pH 7.9), 10% glycerol, 0.1% Triton X-100, 0.1 M NaCl, 0.5 mM PMSF). The digested DNA was bound to the column in three successive loadings in HMBD buffer. DNA was eluted in a linear gradient of HMBD buffer ranging from 0.1 M NaCl to 1.0 M NaCl by FPLC (Waters 650). In all, 30 2-ml fractions were collected. DNA was ethanol precipitated and resuspended in 20 ml TE buffer. The presence of specific CpG island fragments in each fraction was assayed by PCR amplification using 1 ml resuspended DNA as template and primer sets that anneal within the MseI restriction fragment that includes the CpG island. Primer sequences and detailed PCR protocols are available upon request. PCR products were electrophoresed in 2.0% agarose/TAE gels and visualized by staining with GelStar. Band intensities were quantitated using ChemiImager 4000 software (Alpha Innotech). The sum of intensity values of every three consecutive fractions (approximately 100 mM NaCl steps) was divided by the total sum of all product intensities. These values were plotted to visualize elution throughout the separation gradient.
